Alfred Reiter
Impact in
- Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 88
- Hematology 45
- Acute Myeloid Leukemia Research 32
- Hematopoietic Stem Cell Transplantation 18
- Co-authors
- Martin SchrappeHelmut GadnerMartin ZimmermannG. HenzeHansjörg RiehmWolfgang LudwigJochen HarbottBirgit Burkhardt
- Journals
- Blood (41 papers)Journal of Clinical Oncology (20 papers)British Journal of Haematology (17 papers)Leukemia (7 papers)Pediatric Blood & Cancer (6 papers)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Alfred Reiter
183 papers receiving 10.0k citations
Peers
Comparison fields: 5 of 120
- Hematology 3.1k
- Pathology and Forensic Medicine 3.8k
- Public Health, Environmental and Occupational Health 5.0k
- Pediatrics, Perinatology and Child Health 2.9k
- Neurology 1.8k
Countries citing papers authored by Alfred Reiter
This map shows the geographic impact of Alfred Reiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Reiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Reiter more than expected).
Fields of papers citing papers by Alfred Reiter
This network shows the impact of papers produced by Alfred Reiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Reiter. The network helps show where Alfred Reiter may publish in the future.
Co-authors
The 25 scholars most cited alongside Alfred Reiter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 30 | |
| 2 | Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls | 2017 | 7 |
| 3 | 2017 | 32 | |
| 4 | 2012 | 1 | |
| 5 | 2011 | 31 | |
| 6 | 2006 | 112 | |
| 7 | 2006 | 3 | |
| 8 | 2006 | 50 | |
| 9 | NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. | 2004 | 29 |
| 10 | 2004 | 46 | |
| 11 | 2002 | 17 | |
| 12 | 1997 | 55 | |
| 13 | 1997 | 6 | |
| 14 | 1994 | 164 | |
| 15 | 1994 | 15 | |
| 16 | 1994 | 35 | |
| 17 | 1994 | 83 | |
| 18 | 1994 | 17 | |
| 19 | 1990 | 3 | |
| 20 | 1988 | 7 |
About Alfred Reiter
Alfred Reiter is a scholar working on Pathology and Forensic Medicine, Hematology, Public Health, Environmental and Occupational Health, Genetics and Neurology, having authored 185 papers that have together received 10.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (97 papers), Lymphoma Diagnosis and Treatment (88 papers), Acute Myeloid Leukemia Research (32 papers), Childhood Cancer Survivors' Quality of Life (26 papers), CNS Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (20 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Hematopoietic Stem Cell Transplantation (18 papers). The work is most often cited by research in Hematology (3.1k citations), Pathology and Forensic Medicine (3.8k citations), Public Health, Environmental and Occupational Health (5.0k citations), Pediatrics, Perinatology and Child Health (2.9k citations) and Neurology (1.8k citations). Alfred Reiter has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include Martin Schrappe, Helmut Gadner, Martin Zimmermann, G. Henze, Hansjörg Riehm, Martin Zimmermann, Wolfgang Ludwig, Jochen Harbott, Birgit Burkhardt and Karl Welte. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Leukemia and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.